|
|
||||||||
Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, Canada
The cytokine IL-12 manifests its biological activity via
interaction with a heterodimeric receptor (IL-12R) present on activated
T and NK cells. The cDNAs for two IL-12R subunits have been cloned from
human and mouse and designated IL-12Rß1 and IL-12Rß2. The
expression of IL-12Rß2 on T cells is influenced by cytokines,
particularly IL-4, IL-12, and IFN-
; however, little is known
regarding regulation of IL-12R expression on NK cells. In this study we
show that murine NK cells differentiate into IL-12Rß2low
and IL-12Rß2high subsets after in vitro stimulation with
IL-2 in the absence of exogenous polarizing cytokines. Subset
development occurs gradually as NK cells expand in vitro and is
generally complete by 812 days of culture. Once established,
IL-12Rß2low and IL-12Rß2high subsets are
highly stable in vitro and can be maintained for at least 20 days after
FACS sorting. Formation of these NK subsets appears to be strain
independent. Flow cytometric analyses demonstrate that both subsets
express a number of NK-associated markers, including NK1.1, DX-5,
Ly-49A, and Ly-49C, but that the Ly-49G2 class I inhibitory receptor is
expressed predominantly on the IL-12Rß2high population.
Both IL-12Rß2low and IL-12Rß2high NK cells
respond to exogenous IL-12 by rapid production of high levels of
IFN-
and increased lytic activity against NK-sensitive YAC-1 target
cells. Analyses of cytokine gene expression by RNase protection assay
indicated that similar to the recently described human NK1 subset, both
IL-12Rß2high and IL-12Rß2low murine NK
subsets expressed high levels of IFN-
, whereas neither subset
expressed mRNA for the NK2-associated cytokines IL-5 and
IL-13.
This article has been cited by other articles:
![]() |
Z. Zhao, S. Yu, D. C. Fitzgerald, M. Elbehi, B. Ciric, A. M. Rostami, and G.-X. Zhang IL-12R{beta}2 Promotes the Development of CD4+CD25+ Regulatory T Cells J. Immunol., September 15, 2008; 181(6): 3870 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deniz, G. Erten, U. C. Kucuksezer, D. Kocacik, C. Karagiannidis, E. Aktas, C. A. Akdis, and M. Akdis Regulatory NK Cells Suppress Antigen-Specific T Cell Responses J. Immunol., January 15, 2008; 180(2): 850 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Yun, A. Lundgren, J. Azem, A. Sjoling, J. Holmgren, A.-M. Svennerholm, and B. S. Lundin Natural Killer Cells and Helicobacter pylori Infection: Bacterial Antigens and Interleukin-12 Act Synergistically To Induce Gamma Interferon Production Infect. Immun., March 1, 2005; 73(3): 1482 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeda, E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver Blood, March 1, 2005; 105(5): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Salem, A. N. Kadima, Y. Zhou, C. L. Nguyen, M. P. Rubinstein, M. Demcheva, J. N. Vournakis, D. J. Cole, and W. E. Gillanders Paracrine Release of IL-12 Stimulates IFN-{gamma} Production and Dramatically Enhances the Antigen-Specific T Cell Response after Vaccination with a Novel Peptide-Based Cancer Vaccine J. Immunol., May 1, 2004; 172(9): 5159 - 5167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1 J. Biol. Chem., November 8, 2002; 277(46): 43735 - 43740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Strengell, T. Sareneva, D. Foster, I. Julkunen, and S. Matikainen IL-21 Up-Regulates the Expression of Genes Associated with Innate Immunity and Th1 Response J. Immunol., October 1, 2002; 169(7): 3600 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lassmann, C. Kincaid, V. C. Asensio, and I. L. Campbell Induction of Type 1 Immune Pathology in the Brain Following Immunization Without Central Nervous System Autoantigen in Transgenic Mice With Astrocyte-Targeted Expression of IL-12 J. Immunol., November 1, 2001; 167(9): 5485 - 5493. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |